Compare DSY & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DSY | CLGN |
|---|---|---|
| Founded | 2020 | 2004 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.9M | 33.8M |
| IPO Year | N/A | N/A |
| Metric | DSY | CLGN |
|---|---|---|
| Price | $0.35 | $1.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $11.50 |
| AVG Volume (30 Days) | ★ 124.0K | 20.3K |
| Earning Date | 01-01-0001 | 11-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 120.37 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $7,323,356.00 | $2,475,000.00 |
| Revenue This Year | N/A | $1,617.28 |
| Revenue Next Year | N/A | $83.54 |
| P/E Ratio | $28.97 | ★ N/A |
| Revenue Growth | 16.37 | ★ 280.77 |
| 52 Week Low | $0.32 | $1.31 |
| 52 Week High | $7.33 | $4.98 |
| Indicator | DSY | CLGN |
|---|---|---|
| Relative Strength Index (RSI) | 19.08 | 38.23 |
| Support Level | $0.32 | $1.77 |
| Resistance Level | $0.43 | $2.08 |
| Average True Range (ATR) | 0.02 | 0.15 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 21.87 | 20.83 |
Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, distribution, and sales of personal care products and other consumer goods. Operating under a consumer-to-manufacturer and merchant (C2M) model, the company integrates online and offline operations to enhance customer engagement, product innovation, and marketing efficiency. Specializing in feminine hygiene products such as sterilized feminine pads, menstrual pants, and related items, Big Tree Cloud leverages its platform to consolidate resources within China's personal care industry while building a consumer community that provides direct feedback and product insights.
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.